We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Top Analyst Reports for UnitedHealth, Broadcom & CVS Health
Read MoreHide Full Article
Tuesday, December 11, 2018
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH - Free Report) , Broadcom (AVGO - Free Report) and CVS Health (CVS - Free Report) . These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
UnitedHealth’s shares have outperformed the Zacks Medical Insurance industry's rally year to date (up +20.9% vs. +20.5%). The Zacks analyst thinks the company's performance is being backed by higher revenues and strength in both segments — UnitedHealthcare and Optum — plus membership growth.
The company's robust Government business is also driving long-term growth. Its international business and strong capital position are other positives. The company’s raised earnings guidance for 2018 should instill optimism among its investors. However, the company is seeing membership declines in Commercial segment.
Shares of Broadcom have underperformed the Zacks Electronics - Semiconductors industry over the past year, losing -7.5% vs. a -5.8% decline. Broadcom reported stellar fourth-quarter results and provided an encouraging fiscal 2019 outlook.
The Zacks analyst thinks the company is benefiting from strong demand for its wireless solutions and expanding product portfolio, which makes it well-positioned to address the needs of rapidly growing technologies like IoT and 5G. Strong ties with leading OEMs across multiple target markets will help the company to gain key insights into the requirements of customers.
Broadcom is a leading player in the semiconductor market based on its multiple target markets, accretive acquisitions and strong cash flow. Nevertheless, the company faces intensifying competition and integration risks due to frequent acquisitions. The company’s leveraged balance sheet and customer concentration continue to be headwinds.
CVS Health’s shares have underperformed the Zacks Retail Pharmacies and Drug Stores industry in the past six months, gaining +10.5% versus +14.9%. On November 29, CVS Health completed the $70-billion consolidation of insurance-giant Aetna.
The culmination of this huge deal marks the creation of a new healthcare powerhouse, which combines CVS Health’s broad pharmacy business with Aetna’s giant insurance base. In this regard the Zacks analyst stresses that over the past few quarters, the company has consistently demonstrated strong Pharmacy Services performance, benefiting from the upside in the specialty services.
Also, Retail/LTC comparisons are encouraging of late. Strong 2019 PBM selling season is another upside. On the flip side, the company fears it will witness fewer RFP (Requests for Proposals) opportunities in the market than what it has seen over the past few years. According to CVS Health, Omnicare business performance should continue to remain soft through the second-half of 2018.
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trendsand Earnings Previewreports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Top Analyst Reports for UnitedHealth, Broadcom & CVS Health
Tuesday, December 11, 2018
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH - Free Report) , Broadcom (AVGO - Free Report) and CVS Health (CVS - Free Report) . These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
UnitedHealth’s shares have outperformed the Zacks Medical Insurance industry's rally year to date (up +20.9% vs. +20.5%). The Zacks analyst thinks the company's performance is being backed by higher revenues and strength in both segments — UnitedHealthcare and Optum — plus membership growth.
The company's robust Government business is also driving long-term growth. Its international business and strong capital position are other positives. The company’s raised earnings guidance for 2018 should instill optimism among its investors. However, the company is seeing membership declines in Commercial segment.
(You can read the full research report on UnitedHealth here >>>).
Shares of Broadcom have underperformed the Zacks Electronics - Semiconductors industry over the past year, losing -7.5% vs. a -5.8% decline. Broadcom reported stellar fourth-quarter results and provided an encouraging fiscal 2019 outlook.
The Zacks analyst thinks the company is benefiting from strong demand for its wireless solutions and expanding product portfolio, which makes it well-positioned to address the needs of rapidly growing technologies like IoT and 5G. Strong ties with leading OEMs across multiple target markets will help the company to gain key insights into the requirements of customers.
Broadcom is a leading player in the semiconductor market based on its multiple target markets, accretive acquisitions and strong cash flow. Nevertheless, the company faces intensifying competition and integration risks due to frequent acquisitions. The company’s leveraged balance sheet and customer concentration continue to be headwinds.
(You can read the full research report on Broadcom here >>>).
CVS Health’s shares have underperformed the Zacks Retail Pharmacies and Drug Stores industry in the past six months, gaining +10.5% versus +14.9%. On November 29, CVS Health completed the $70-billion consolidation of insurance-giant Aetna.
The culmination of this huge deal marks the creation of a new healthcare powerhouse, which combines CVS Health’s broad pharmacy business with Aetna’s giant insurance base. In this regard the Zacks analyst stresses that over the past few quarters, the company has consistently demonstrated strong Pharmacy Services performance, benefiting from the upside in the specialty services.
Also, Retail/LTC comparisons are encouraging of late. Strong 2019 PBM selling season is another upside. On the flip side, the company fears it will witness fewer RFP (Requests for Proposals) opportunities in the market than what it has seen over the past few years. According to CVS Health, Omnicare business performance should continue to remain soft through the second-half of 2018.
(You can read the full research report on CVS Health here >>>).
Other noteworthy reports we are featuring today include ConocoPhillips (COP - Free Report) , FedEx (FDX - Free Report) and Oracle (ORCL - Free Report) .
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
It's not the one you think.
See This Ticker Free >>
Mark Vickery
Senior Editor
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>